A Study in Healthy Men to Test How BI 1815368 is Processed in the Body

Recruiting now · Phase 1

Conditions studied: Healthy

In brief

The main objectives are: * To assess mass balance by determining the extent of recovery of total \[¹⁴C\]-radioactivity in urine and faeces after a single oral dose administration of BI 1815368 (C-14) (test treatment T) in healthy male trial participants. * To investigate the absolute bioavailability of BI 1815368 using a single, concomitant intravenous micro-dose administration of BI 1815368 (C13) (reference treatment R). * To provide plasma, urine, and faecal samples

Key facts

Study ID
NCT07693218
Run by
Boehringer Ingelheim
People needed
10
Starts
2026-07-16
Expected to finish
2026-09-05
Last updated by the study team
2026-07-23

Who can join

Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.